Home/Filings/4/0001538604-26-000002
4//SEC Filing

Ricks David A 4

Accession 0001538604-26-000002

CIK 0000059478other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 4:29 PM ET

Size

11.9 KB

Accession

0001538604-26-000002

Research Summary

AI-generated summary of this filing

Updated

Eli Lilly (LLY) CEO David Ricks Exercises RSUs, Sells $14.8M for Taxes

What Happened
David A. Ricks, President, Chairman and CEO of Eli Lilly & Co. (LLY), converted 31,932 restricted stock units (RSUs) into shares on 2026-02-01 and had 14,296.654 of those shares disposed to satisfy tax withholding, producing $14,827,775. The RSU conversion is reported as an exercise/conversion of a derivative (code M) and the withholding sale is reported under code F.

Key Details

  • Transaction date: 2026-02-01; Form 4 filed: 2026-02-03 (timely).
  • Conversion: 31,932 RSUs converted to common shares (code M) at $0.00 per share (RSUs convert without exercise price).
  • Withholding sale: 14,296.654 shares disposed at $1,037.15 per share for proceeds of $14,827,775 (code F — tax withholding).
  • Net shares delivered to Ricks after withholding: 31,932 − 14,296.654 = 17,635.346 net shares retained from this conversion.
  • Footnotes: F1 — reporting person disclaims beneficial ownership except to pecuniary interest; F2 — each RSU equals a contingent right to one share.
  • Filing appears timely (not marked late).

Context
This was a routine RSU conversion with a portion of shares withheld/sold to cover tax obligations (a common post‑award tax-withholding mechanism), not an open-market purchase or a discretionary sale for investment purposes. For derivative transactions like RSU conversions, the conversion to shares followed by withholding/sale typically reflects tax settlement rather than an expression of market sentiment.

Insider Transaction Report

Form 4
Period: 2026-02-01
Ricks David A
DirectorPresident, Chair, and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-01+31,932547,098.167 total
  • Tax Payment

    Common Stock

    2026-02-01$1037.15/sh14,296.654$14,827,775532,801.513 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F2]
    2026-02-0131,9320 total
    From: 2026-02-01Exp: 2026-02-01Common Stock (31,932 underlying)
Holdings
  • Common Stock

    [F1]
    (indirect: By David A. Ricks 2025 GRAT)
    6,685
  • Common Stock

    (indirect: By David A. Ricks 2022 GRAT)
    54,117
  • Common Stock

    [F1]
    (indirect: By Trust)
    300
  • Common Stock

    [F1]
    (indirect: By David A. Ricks SLAT)
    68,656
  • Common Stock

    (indirect: By 401(k))
    7,311.26
Footnotes (2)
  • [F1]The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Signature
/s/ Jonathan Groff for David A. Ricks, pursuant to authorization on file|2026-02-03

Issuer

ELI LILLY & Co

CIK 0000059478

Entity typeother

Related Parties

1
  • filerCIK 0001538604

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:29 PM ET
Size
11.9 KB